Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
9.06
-0.01 (-0.11%)
Oct 10, 2025, 1:24 PM EDT - Market open

Mersana Therapeutics Revenue

Mersana Therapeutics had revenue of $3.06M in the quarter ending June 30, 2025, with 33.28% growth. This brings the company's revenue in the last twelve months to $34.77M, up 16.14% year-over-year. In the year 2024, Mersana Therapeutics had annual revenue of $40.50M with 9.88% growth.

Revenue (ttm)
$34.77M
Revenue Growth
+16.14%
P/S Ratio
1.29
Revenue / Employee
$340,873
Employees
102
Market Cap
45.22M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202440.50M3.64M9.88%
Dec 31, 202336.86M10.27M38.65%
Dec 31, 202226.58M26.54M61,716.28%
Dec 31, 202143.00K-785.00K-94.81%
Dec 31, 2020828.00K-41.30M-98.03%
Dec 31, 201942.12M31.53M297.61%
Dec 31, 201810.59M-6.95M-39.62%
Dec 31, 201717.55M-7.63M-30.30%
Dec 31, 201625.17M14.81M142.99%
Dec 31, 201510.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings